Indice de Résistance Urétrale (URI) : Un Nouveau Paramètre pour le Diagnostic de l'Obstruction Urétrale (URI)
Indice de résistance urétrale (URI) : Un nouveau paramètre uroflowmétrique dans le diagnostic non invasif de l'obstruction urétrale
This prospective observational study aims to evaluate the diagnostic accuracy of a new, non-invasive uroflowmetry parameter called the Urethral Resistive Index (URI) for detecting urethral stricture in men. Currently, diagnosing urethral stricture often requires invasive procedures like surgery or pressure-flow studies. This research seeks to develop URI as a practical and painless screening tool that could reduce the need for such invasive interventions.
Study Procedures:
A total of 60 male participants (30 with suspected urethral stricture and 30 healthy volunteers) will be enrolled. Participants will undergo two standard, non-invasive uroflowmetry (voiding) tests. The first test is a routine natural voiding session. The second test involves a "forced voiding" (Valsalva maneuver) once the participant feels a sufficient urge to urinate again. The URI is then calculated by comparing the flow rates of these two sessions.
Goals and Benefits: The primary goal is to determine the optimal "cut-off" value of the URI that accurately identifies a surgically proven urethral stricture. By demonstrating URI's effectiveness, the study aims to expedite the diagnostic process and spare patients from unnecessary invasive tests. The procedure involves minimal risk, primarily temporary discomfort or psychological stress during the voiding tests
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
This methodological study is designed as a prospective, cross-sectional, and observational diagnostic accuracy study. The primary objective is to evaluate the clinical validity of the Urethral Resistive Index (URI), a novel non-invasive parameter, in the diagnosis of urethral stricture.
Study Population and Groups:
The study will include a total of 60 male participants aged between 18 and 80 years.
Stricture Group (n=30): Patients planned for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the presence of the stricture is confirmed intraoperatively.
Control Group (n=30): Healthy male volunteers without lower urinary tract symptoms, matched for age.
Methodology: The study focuses on comparing standard uroflowmetry with "forced" uroflowmetry using the Valsalva maneuver. All clinical and uroflowmetric parameters will be collected at the Ankara Bilkent City Hospital Urology Clinic.
Natural Uroflowmetry: Participants will perform a standard uroflowmetry test. Forced Uroflowmetry: After reaching sufficient bladder fullness again, participants will perform a second test using the Valsalva maneuver (forced voiding).
Calculation: The URI will be calculated using the formula:
URI= Qmax,forced/ Qmax,normal
Statistical Analysis: The diagnostic performance of the URI will be evaluated using Receiver Operating Characteristic (ROC) curve analysis. The Area Under the Curve (AUC) will be calculated, and the optimal cut-off value for determining urethral stricture will be identified with corresponding sensitivity and specificity values. Correlation between URI and clinical symptom scores, such as the International Prostate Symptom Score (IPSS), will also be analyzed.
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Yusuf Gökkurt
- Numéro de téléphone: +90-506-791-0557
- E-mail: yusufgokkurt@gmail.com
Lieux d'étude
-
-
Universiteler
-
Ankara, Universiteler, Turquie (Türkiye), 06800
- Recrutement
- Ankara Bilkent City Hospital
-
Contact:
- Yusuf Gökkurt, MD
- Numéro de téléphone: +90 506 791 0557
- E-mail: yusufgokkurt@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
The study population consists of 60 male participants, aged 18 to 80 years, recruited from the Urology Outpatient Clinic at Ankara Bilkent City Hospital. The population is divided into two distinct groups: a Stricture Group (n=30) comprising patients with suspected urethral stricture whose diagnosis is confirmed intraoperatively during scheduled surgery, and a Control Group (n=30) comprising healthy male volunteers with a similar age distribution and no lower urinary tract symptoms. Participants are selected based on their clinical presentation and willingness to undergo a specialized two-stage uroflowmetry protocol.
La description
Inclusion Criteria:
- Male participants aged between 18 and 80 years.
- For the Stricture Group: Patients scheduled for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the diagnosis is confirmed intraoperatively.
- For the Control Group: Healthy male volunteers without any lower urinary tract symptoms.
- Voluntary signing of the Informed Consent Form.
Exclusion Criteria:
- Voiding volume less than 150 mL.
- Causes of obstruction other than stricture, such as Benign Prostatic Hyperplasia (BPH).
- Diagnosis of neurogenic bladder dysfunction or a history of neurological disease affecting bladder function.
- Presence of severe comorbidities.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Nombre de groupes / cohortes
Cohortes et interventions
Groupe / CohorteGroupe / Cohorte |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Stricture Group
Patients with suspected urethral stricture scheduled for surgery (urethroplasty or internal urethrotomy), with the diagnosis confirmed intraoperatively. |
Performing natural and forced (Valsalva) uroflowmetry sessions to calculate the Urethral Resistive Index. |
|
Control Group
Healthy male volunteers in a similar age range as the stricture group, without any lower urinary tract symptoms. |
Performing natural and forced (Valsalva) uroflowmetry sessions to calculate the Urethral Resistive Index. |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Urethral Resistive Index (URI)
Délai: At the time of the uroflowmetry procedure (Baseline)
|
A novel non-invasive uroflowmetric parameter calculated to assess the resistance of the urethra during voiding. It is derived using the formula: URI=Qmax,natural/Qmax,forced. |
At the time of the uroflowmetry procedure (Baseline)
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Publications et liens utiles
Publications générales
- Kranse R, van Mastrigt R. Bladder outlet resistance. J Urol. 2003 Mar;169(3):1007-10. doi: 10.1097/01.ju.0000052693.58772.23.
- Spyropoulos E, Galanakis I, Deligiannis D, Spyropoulou A, Kotsiris D, Panagopoulos A, Mavrikos S. Flow resistive forces index (QRF): Development and clinical applicability assessment of a novel measure of bladder outlet resistance, aiming to enhance the diagnostic performance of uroflowmetry. Low Urin Tract Symptoms. 2020 Sep;12(3):190-197. doi: 10.1111/luts.12301. Epub 2020 Jan 30.
- Krukowski J, Kaluzny A, Klacz J, Piatkowska A, Matuszewski M. Evaluation of non-invasive tests as diagnostic tools in assessment of bladder outlet obstruction severity in men with anterior urethral stricture. Cent European J Urol. 2021;74(3):422-428. doi: 10.5173/ceju.2021.3.153.R1. Epub 2021 Jul 27.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- TABED 1/2090/2026
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
To protect participant privacy and maintain data confidentiality according to local institutional regulations
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .